We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Evotec SE (EVT) NPV

Sell:€9.75 Buy:€9.76 Change: €0.13 (1.31%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€9.75
Buy:€9.76
Change: €0.13 (1.31%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€9.75
Buy:€9.76
Change: €0.13 (1.31%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Contact details

Address:
Essener Bogen 7
HAMBURG
22419
Germany
Telephone:
+49 (40) 560810
Website:
https://www.evotec.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
EVT
ISIN:
DE0005664809
Market cap:
€1.79 billion
Shares in issue:
177.30 million
Sector:
Life Sciences Tools & Services
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Iris Loew-Friedrich
    Independent Chairwoman of the Supervisory Board
  • Christian Wojczewski
    Chief Executive Officer
  • Roland Sackers
    Independent Vice Chairman of the Supervisory Board
  • Laetitia Rouxel
    Chief Financial Officer, Member of the Management Board
  • Craig Johnstone
    Chief Operating Officer, Member of the Management Board
  • Aurelie Dalbiez
    Chief People Officer, Member of the Management Board
  • Cord Dohrmann
    Chief Scientific Officer, Member of the Management Board

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.